Minor Use Minor Species Development of Drugs: Research Project Grant

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, more commonly referred to as NIH, is an agency operating under the United States Department of Health and Human Services that is primarily accountable for funding and supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all designed to contribute to the agency's general mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

The grant project seeks to solicit applications and proposals from eligible institutions and organizations who are willing to design and develop brand new animal drugs that are solely exclusive for minor use in major species or minor species.

In the year 2004, the The Minor Use and Minor Species Animal Health Act was constituted and this law enabled veterinarians to have legal access to more medications that are effective in the management and treatment of disease conditions that are common in minor animal species and minor uses in major animal species.

  (continued...)

Minor Use Minor Species Development of Drugs: Research Project Grant
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on philanthropy giving and community grants.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Advanced Neural Prosthetics Research and Development Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to establish the Advanced Neural Prosthetics Research and Development Program.

---

Basic Research on HIV Persistence Program
In keeping with this mission, the National Institutes of Health has recently constituted the establishment of the Basic Research on HIV Persistence Program in an attempt to increase our understanding of the persistence of HIV-1 infections in patients under highly active anti-retroviral therapy (HAART).

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---